This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted therapies. It serves as a key intermediate in the synthesis of small molecule inhibitors, especially those targeting specific enzymes or receptors involved in disease pathways. Its boronic acid group is particularly valuable in Suzuki-Miyaura cross-coupling reactions, a widely used method in organic synthesis to form carbon-carbon bonds, which is essential for creating complex pharmaceutical compounds. Additionally, its structure, incorporating a piperazine moiety, enhances its ability to interact with biological targets, making it a useful component in the design of drugs for conditions such as cancer, inflammation, or neurological disorders.